Handbook on Injectable Drugs

In-app purchases
4.5
127 reviews
50K+
Downloads
Content rating
Everyone
Screenshot image
Screenshot image
Screenshot image
Screenshot image
Screenshot image
Screenshot image
Screenshot image
Screenshot image
Screenshot image
Screenshot image
Screenshot image
Screenshot image
Screenshot image
Screenshot image
Screenshot image
Screenshot image
Screenshot image
Screenshot image
Screenshot image
Screenshot image
Screenshot image
Screenshot image
Screenshot image
Screenshot image

About this app

“Try before you buy" - Download the FREE App, which includes sample content. In-App purchase required to unlock all content.

Based on 23rd edition, American Society of Health-System Pharmacists the most comprehensive reference on injectable drug data. Current 2023 edition features 18 new monographs and nearly 200 new references for a total of over 24,000 total compatibility pairs.

For more than 40 years ASHP has published the most trusted resource for injectable drug information. Our new ASHP® Injectable Drug InformationTM now delivers the same high-quality content that you can expect from ASHP with even MORE of the information you need to make decisive patient care decisions.

The digital content of ASHP® Injectable Drug InformationTM 2023 is interactive, mobile, and updated quarterly. Includes monographs to Extended Stability for Parenteral Drugs, forming a single, comprehensive resource on injectable drug information.
Backed by quality, peer-reviewed published literature and authored under the editorial authority of ASHP, it is a must-have resource for every pharmacy.

Key Features
* Quick data search for 358 drugs
* 417 monographs on parenteral drugs available in the United States and in other countries
* Monographs cross-referenced with American Society of Health-System Pharmacists (AHFS) Drug Information through AHFS classification numbers
* More than 500 revisions to existing monographs (affecting nearly 60% of the existing monographs) have been accomplished to update information on stability, compatibility, and safety (e.g., Food and Drug Administration [FDA] MedWatch alerts) and to provide more specific referencing of manufacturer information and other enhancements to the more than 24,100 compatibility pairs contained in ASHP® Injectable Drug Information™ 2023.
* How to prepare, store and administer drugs
* Quick identification of drug compatibility
* Tabulated results from primary research on the compatibility of the listed drug with infusion solutions and other drugs
* Four compatibility tables are provided for each drug: solution, additive, syringe, and Y-site
* Storage requirements and general stability information, including pH, freezing, exposure to light, sorption and filtration characteristics, and repackaging information
* Key product data including common sizes, strengths, volumes, and forms in which the drug is supplied. Also includes pH, osmotic value, and other important product information
* Parenteral Drugs by Caryn Bing and Anna Nowobilski-Vasilios. This extended stability information is specifically designed for use in home and other infusion practices

Content licensed from printed edition ISBN 10: 1585286834 ISBN 13: 9781585286836

SUBSCRIPTION :
Please purchase a yearly auto-renewing subscription to receive content access and available updates.

Yearly auto-renewing payments- $49.99

Payment will be charged to your Google Play Account at confirmation of purchase. Initial purchase includes a 1-year subscription with regular content updates. Your subscription will automatically renews unless auto-renew is turned off at least 24-hours before the end of the current period. If you do not choose to renew, you can continue to use the product but will not receive content updates. Subscription may be managed by the user and auto-renewal can be disabled at any time by going to Google Play Store. Tap Menu Subscriptions, then select the subscription you want to modify. Follow the instructions on the screen to pause, cancel or change your subscription. Any unused portion of a free trial period will be forfeited when you purchase a subscription, where applicable.

If you have any questions or comments, email us any time: customersupport@skyscape.com or call 508-299-30000

Privacy Policy - https://www.skyscape.com/terms-of-service/privacypolicy.aspx
Terms and Conditions - https://www.skyscape.com/terms-of-service/licenseagreement.aspx

Editor(s): ASHP
Publisher: American Society of Health-System Pharmacists
Updated on
Oct 20, 2023

Data safety

Safety starts with understanding how developers collect and share your data. Data privacy and security practices may vary based on your use, region, and age. The developer provided this information and may update it over time.
No data shared with third parties
Learn more about how developers declare sharing
This app may collect these data types
Personal info
Data isn’t encrypted
Data can’t be deleted

Ratings and reviews

4.4
121 reviews
onco learn
March 14, 2024
Amazing app ,kindly I have one hope as we work in NCI and we serve alot of patients so if app team can open all antineplastic and all antimicrobial section only for free content .i will be more thankful
2 people found this review helpful
Did you find this helpful?
Skyscape Medpresso Inc
March 14, 2024
Dear User, We are always working to add more sources in the updates. Thank you for sharing your thoughts with us :)
A Google user
April 20, 2020
Accurate and simple
38 people found this review helpful
Did you find this helpful?
Skyscape Medpresso Inc
April 21, 2020
Thank you so much for your review!
rajabu kimosa
June 11, 2020
All over good backup tool
40 people found this review helpful
Did you find this helpful?

What's new

- Keep your app updated to get the latest experience on your Android phones & tablets
- We want you to get notified about exclusive offers, promotions, & discounts. This updates does this directly through in-app notifications
- We have also updated our billing system with the latest Google Billing Library to ensure smoother and more secure transactions.
- Our app is now compatible with Android 13, ensuring compatibility with the latest features and improvements offered by the Android platform.